Title Collection Author Date
'Barely-Disguised' Dividend Hike Boosts AstraZeneca Shares Ahead of Pay Vote Equity Research & Insights Ollie Smith 11/04/24
Soaring Ozempic Demand Pushes Novo Nordisk Shares to Record High Equity Research & Insights Karen Andersen, CFA 01/02/24
Novo Nordisk Earnings: What to Expect on Wednesday Equity Research & Insights Johanna Englundh 29/01/24
AstraZeneca Enters Obesity Market Equity Research & Insights Johanna Englundh 09/11/23
Stock of the Week: Moderna Equity Research & Insights Andrew Willis 05/09/22
UK Innovation Stock of the Week: AstraZeneca Special Report James Gard 20/05/22
What Our Analysts Are Reading in 2022 Education Ollie Smith 04/01/22
Why Pfizer Has a Wide Moat Equity Research & Insights Damien Conover 06/12/21
Stock of the Week: Volkswagen Equity Research & Insights James Gard 19/03/21
Big Pharma, Big Returns? Equity Research & Insights James Gard 15/03/21
Stock of the Week: AstraZeneca Equity Research & Insights James Gard 12/03/21
Should You Invest in the Vaccine Makers? Equity Research & Insights Rentsje de Gruyter 19/01/21
What Next in the Hunt for a Covid-19 Vaccine? Economic Insights Karen Andersen, CFA 04/09/20
Ignore Politics, Innovation is Driving Healthcare Stocks Fund Research & Insights James Gard 24/09/19
Glaxo's Vaccines Division Outperforms Equity Research & Insights James Gard 24/07/19
Reckitt Shares Rise After Suboxone Settlement Equity Research & Insights James Gard 11/07/19
Investor Views: High-Tech and Pharma Shares for my SIPP Investing for Retirement Emma Simon 24/04/19
Top Asian Healthcare Stocks Perspectives External Writer 09/04/19
How to Tap Into the Genetics Revolution Perspectives EdenTree 29/03/19
Can Healthcare Stocks Continue their 2018 Rally? Equity Research & Insights David Brenchley 30/01/19
GSK Pfizer Joint Venture No Impact on Company Value Equity Research & Insights Damien Conover, CFA 20/12/18
Healthcare Stocks Aren't Cheap But Offer Attractive Returns Equity Research & Insights Philip Straehl 22/11/18
Henderson Backs Two Tech Alternative Trusts Investment Trust Research & Insights David Brenchley 25/09/18
Page   1 of 1
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures